Chronic inflammation plays a multifaceted role in carcinogenesis. Mounting evidence from
preclinical and clinical studies suggests that persistent inflammation functions as a driving …

Background In order to review the epidemiologic evidence concerning previous lung
diseases as risk factors for lung cancer, a meta-analysis and systematic review was …

The mechanism by which anti-cancer immunity shapes early carcinogenesis of lung
adenocarcinoma (ADC) is unknown. In this study, we characterize the immune contexture of …

Lung cancer remains a serious public health problem and is the first cause of cancer death
worldwide, and the overall 5-year survival rate for all stages is 14–17% for Non-small-cell …

The lung is a highly specialized organ that facilitates uptake of oxygen and release of
carbon dioxide. Due to its unique structure providing enormous surface area to outside …

To clarify the role of previous lung diseases (chronic bronchitis, emphysema, pneumonia,
and tuberculosis) in the development of lung cancer, the authors conducted a pooled …

Background Despite growing recognition of an etiologic role for inflammation in lung
carcinogenesis, few prospective epidemiologic studies have comprehensively investigated …

There has been conflicting evidence concerning the possible association between
tuberculosis (TB) and subsequent risk of lung cancer. To investigate whether currently …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and its clinical
manifestation, the coronavirus disease 2019 (COVID19) have rapidly spread across the …

Inflammation is a facilitating process for multiple cancer types. It is believed to affect cancer
development and progression through several etiologic pathways, including increased …